(Q44499360)

3 December 2017

Pilot dose-response trial of i.v. ketamine in treatment-resistant depression (English)

1 reference

3 December 2017

5

1 reference

3 December 2017

8

1 reference

3 December 2017

Rosalyn Lai

1

1 reference

3 December 2017

Natalie Katalinic

2

1 reference

3 December 2017

Paul Glue

3

1 reference

3 December 2017

Andrew A Somogyi

4

1 reference

3 December 2017

John Leyden

6

1 reference

3 December 2017

Simon Harper

7

1 reference

3 December 2017

9 June 2014

1 reference

World Journal of Biological Psychiatry

3 December 2017

1 reference

3 December 2017

15

1 reference

3 December 2017

7

1 reference

3 December 2017

579-584

1 reference

Antidepressant effects of ketamine in depressed patients

3 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

Ketamine as a new treatment for depression: a review of its efficacy and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

Patients' perspectives on electroconvulsive therapy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.922697

10.3109/15622975.2014.922697

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference